{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:36:14Z","timestamp":1787884574413,"version":"build-2784847793"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Atrial fibrillation (AF) with excessively high ventricular rates (VR) occurs in dogs with advanced heart disease. Rate control improves clinical signs in these patients. Optimal drug therapy and target VR remain poorly defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Digoxin-diltiazem combination therapy reduces VR more than either drug alone in dogs with high VR AF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Eighteen client-owned dogs (&amp;gt;15\u2003kg) with advanced heart disease, AF, and average VR on 24-hour Holter &amp;gt; 140 beats per minute (bpm).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>After baseline Holter recording, dogs were randomized to digoxin or diltiazem monotherapy, or combination therapy. Repeat Holter evaluation was obtained after 2 weeks; dogs were then crossed over to the other arm (monotherapy or combination therapy) for 2 weeks and a third Holter was acquired. Twenty-four hour average VR, absolute and relative VR changes from baseline, and percent time spent within prespecified VR ranges (&amp;gt;140, 100\u2013140, and &amp;lt;100\u2003bpm) were compared. Correlations between serum drug concentrations and VR were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Digoxin (median, 164\u2003bpm) and diltiazem (median, 158\u2003bpm) decreased VR from baseline (median, 194\u2003bpm) less than the digoxin-diltiazem combination (median, 126\u2003bpm) (P &amp;lt; .008 for each comparison). With digoxin-diltiazem, VR remained &amp;lt;140\u2003bpm for 85% of the recording period, but remained &amp;gt;140\u2003bpm for 88% of the recording period with either monotherapy. Serum drug concentrations did not correlate with VR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>At the dosages used in this study, digoxin-diltiazem combination therapy provided a greater rate control than either drug alone in dogs with AF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2009.0301.x","type":"journal-article","created":{"date-parts":[[2009,4,13]],"date-time":"2009-04-13T11:00:40Z","timestamp":1239620440000},"page":"499-508","source":"Crossref","is-referenced-by-count":58,"title":["Combination Therapy with Digoxin and Diltiazem Controls Ventricular Rate in Chronic Atrial Fibrillation in Dogs Better than Digoxin or Diltiazem Monotherapy: A Randomized Crossover Study in 18 Dogs"],"prefix":"10.1093","volume":"23","author":[{"given":"A.R.M.","family":"Gelzer","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Clinical Sciences, , Ithaca, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Kraus","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Clinical Sciences, , Ithaca, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rishniw","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Clinical Sciences, , Ithaca, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.S.","family":"Mo\u00efse","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Clinical Sciences, , Ithaca, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pariaut","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Clinical Sciences, , Ithaca, NY"},{"name":"Louisiana State University College of Veterinary Medicine, , Baton Rouge, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Jesty","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Clinical Sciences, , Ithaca, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Hemsley","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Cornell University Department of Clinical Sciences, , Ithaca, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,5,1]]},"reference":[{"key":"2026020304295858300_b1","first-page":"111","article-title":"Atrial fibrillation in the dog","volume":"22","author":"Bonagura","year":"1986","journal-title":"Clinical findings in 81 cases"},{"key":"2026020304295858300_b2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1939-1676.1997.tb00474.x","article-title":"Signalment, survival, and prognostic factors in Doberman Pinschers with end-stage cardiomyopathy","volume":"11","author":"Calvert","year":"1997","journal-title":"J Vet Intern Med"},{"key":"2026020304295858300_b3","first-page":"125","article-title":"The prevalence of cardiomyopathy in the Irish Wolfhound","volume":"36","author":"Vollmar","year":"2000","journal-title":"A clinical study of 500 dogs"},{"key":"2026020304295858300_b4","first-page":"473","volume-title":"Small Animal Cardiovascular Medicine","author":"Kittleson","year":"1998"},{"key":"2026020304295858300_b5","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1056\/NEJMe0803289","article-title":"Rhythm control in atrial fibrillation\u2014one setback after another","volume":"358","author":"Cain","year":"2008","journal-title":"N Engl J Med"},{"key":"2026020304295858300_b6","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0002-9149(75)90051-X","article-title":"Inefficacy of \u201ctherapeutic\u201d serum levels of digoxin in controlling the ventricular rate in atrial fibrillation","volume":"35","author":"Goldman","year":"1975","journal-title":"Am J Cardiol"},{"key":"2026020304295858300_b7","first-page":"304","article-title":"Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise","volume":"33","author":"Farshi","year":"1999","journal-title":"A crossover open-label study of five drug regimens"},{"key":"2026020304295858300_b8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1939-1676.2001.tb01591.x","article-title":"Acute cardiovascular effects of diltiazem in anesthetized dogs with induced atrial fibrillation","volume":"15","author":"Miyamoto","year":"2001","journal-title":"J Vet Intern Med"},{"key":"2026020304295858300_b9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.73.2.316","article-title":"Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation","volume":"73","author":"Roth","year":"1986","journal-title":"Circulation"},{"key":"2026020304295858300_b10","first-page":"385","article-title":"Low- and medium-dose diltiazem in chronic atrial fibrillation","volume":"116","author":"Maragno","year":"1988","journal-title":"Comparison with digoxin and correlation with drug plasma levels"},{"key":"2026020304295858300_b11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0002-9149(99)80538-4","article-title":"Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation","volume":"75","author":"Koh","year":"1995","journal-title":"Am J Cardiol"},{"key":"2026020304295858300_b12","first-page":"167","article-title":"Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation","volume":"52","author":"Koh","year":"1995","journal-title":"Randomized crossover study"},{"key":"2026020304295858300_b13","first-page":"101","article-title":"Ventricular arrhythmias in dogs undergoing splenectomy","volume":"23","author":"Marino","year":"1994","journal-title":"A prospective study"},{"key":"2026020304295858300_b14","first-page":"111","article-title":"Retrospective analysis of the clinical utility of ambulatory electrocardiographic (Holter) recordings in syncopal dogs","volume":"13","author":"Miller","year":"1999","journal-title":"44 cases (1991\u20131995)"},{"key":"2026020304295858300_b15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM199308123290701","article-title":"A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators","volume":"329","author":"Mason","year":"1993","journal-title":"N Engl J Med"},{"key":"2026020304295858300_b16","doi-asserted-by":"crossref","first-page":"18H","DOI":"10.1016\/0002-9149(88)90336-0","article-title":"Evaluation of antiarrhythmic therapy using Holter monitoring","volume":"62","author":"Morganroth","year":"1988","journal-title":"Am J Cardiol"},{"key":"2026020304295858300_b17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/01.CIR.88.1.337","article-title":"Clinical competence in ambulatory electrocardiography. A statement for physicians from the AHA\/ACC\/ACP Task Force on Clinical Privileges in Cardiology","volume":"88","author":"Knoebel","year":"1993","journal-title":"Circulation"},{"key":"2026020304295858300_b18","doi-asserted-by":"crossref","first-page":"27D","DOI":"10.1016\/S0002-9149(02)03376-3","article-title":"Risk and benefits of rate control versus maintenance of sinus rhythm","volume":"91","author":"Saxonhouse","year":"2003","journal-title":"Am J Cardiol"},{"key":"2026020304295858300_b19","first-page":"e149","article-title":"Task Force on Practice Guidelines, American College of Cardiology\/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC\/AHA\/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary","volume":"48","author":"Fuster","year":"2006","journal-title":"A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation)"},{"key":"2026020304295858300_b20","first-page":"122","volume-title":"An Introduction to Medical Statistics","author":"Bland","year":"2000"},{"key":"2026020304295858300_b21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0002-8703(82)90530-0","article-title":"Intracardiac electrophysiologic study of intravenous diltiazem and combined diltiazem-digoxin in patients","volume":"103","author":"Mitchell","year":"1982","journal-title":"Am Heart J"},{"key":"2026020304295858300_b22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1046\/j.1440-1681.2001.03454.x","article-title":"Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation","volume":"28","author":"Tse","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2026020304295858300_b23","first-page":"1424","article-title":"Pharmacokinetics and bioavailability of diltiazem (CRD-401) in dog","volume":"27","author":"Kohno","year":"1977","journal-title":"Arzneimittelforschung"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2009.0301.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/23\/3\/499\/66673342\/j.1939-1676.2009.0301.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/23\/3\/499\/66673342\/j.1939-1676.2009.0301.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:30:17Z","timestamp":1770111017000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/23\/3\/499\/8449867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,1]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,5,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2009.0301.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,5]]},"published":{"date-parts":[[2009,5,1]]}}}